http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#Head http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#assertion http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#provenance http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#pubinfo http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#assertion http://purl.obolibrary.org/obo/DOID_115 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_115 http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00727 http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#association http://www.w3.org/2000/01/rdf-schema#label "Nitroglycerin in 5% Dextrose Injection is contraindicated in patients who are allergic to it. In patients with pericardial tamponade, restrictive cardiomyopathy, or constrictive pericarditis, cardiac output is dependent upon venous return. Intravenous nitroglycerin is contraindicated in patients with these conditions. Nitroglycerin is also contraindicated in patients with increased intracranial pressure. Do not use Nitroglycerin in 5% Dextrose Injection in patients who are taking certain drugs for erectile dysfunction (phosphodiesterase inhibitors) such as sildenafil, tadalafil, or vardenafil. Concomitant use can cause severe hypotension, syncope, or myocardial ischemia. Do not use Nitroglycerin in 5% Dextrose Injection in patients who are taking the soluble guanylate cyclase stimulator riociguat. Concomitant use can cause hypotension." http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB00727 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#provenance http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#pubinfo http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#sig http://purl.org/nanopub/x/hasSignature JqtSpnJRzrbHAcHtc6npZZHAbCRlLOH/OFVaiaqachemZF0xLsLBULKT3TlO5lCf46DKDfLofrIdXoTv29rQr+gfQyKBBIt3+TiHSA0WDheVtgA/vkAOnUo5erEVzLUZENuApZa56uySiUzrr4xHHwRq9q7MSqBXhcH+pcZ5u0Y= http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA http://purl.org/dc/terms/created 2021-08-23T18:47:41.852+02:00 http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY